KZIA vs CBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 16, 2026

KZIA

56.5
AI Score
VS
KZIA Wins

CBIO

33.9
AI Score

Investment Advisor Scores

KZIA

57score
Recommendation
HOLD

CBIO

34score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric KZIA CBIO Winner

Relative Price Performance (Last 90 Days)

KZIA 1M: -26.5% · 3M: -29.1% CBIO 1M: -22.8% · 3M: -15.6%

Current Technical Phase

KZIA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -9.2%), weak momentum, RSI 34

RSI (14): 34.0 · Price: $9.27

CBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 36

RSI (14): 35.6 · Price: $14.32

Fundamentals Snapshot

Metric KZIA CBIO
Market Cap — —
Forward P/E -542.1 -5.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 3.1% 0.0%
Gross Margin 1.0% 1.0%
Operating Margin -146.4% -14.3%
EPS -7.46 -0.14
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, KZIA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.